Citigroup’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,000
Closed -$3.19M 5614
2024
Q4
$3.19M Hold
27,000
﹤0.01% 2415
2024
Q3
$2.98M Hold
27,000
﹤0.01% 2313
2024
Q2
$2.65M Hold
27,000
﹤0.01% 2113
2024
Q1
$3.02M Hold
27,000
﹤0.01% 2085
2023
Q4
$2.72M Hold
27,000
﹤0.01% 1997
2023
Q3
$2.34M Hold
27,000
﹤0.01% 1888
2023
Q2
$2.55M Buy
+27,000
New +$2.28M ﹤0.01% 1991
2022
Q4
Sell
-50,000
Closed -$3.33M 5792
2022
Q3
$3.33M Buy
+50,000
New +$3.17M ﹤0.01% 1788
2021
Q1
Sell
-156,300
Closed -$8.37M 6345
2020
Q4
$8.37M Sell
156,300
-3,800
-2% -$197K ﹤0.01% 1710
2020
Q3
$7.52M Sell
160,100
-8,100
-5% -$416K ﹤0.01% 1604
2020
Q2
$8.78M Sell
168,200
-45,500
-21% -$2.35M 0.01% 1399
2020
Q1
$10.2M Buy
213,700
+2,500
+1% +$130K 0.01% 1142
2019
Q4
$10.7M Buy
211,200
+5,200
+3% +$269K 0.01% 1442
2019
Q3
$9.72M Buy
206,000
+91,600
+80% +$4.18M 0.01% 1420
2019
Q2
$5.39M Buy
114,400
+42,500
+59% +$1.96M ﹤0.01% 1910
2019
Q1
$3.46M Buy
71,900
+20,100
+39% +$1.01M ﹤0.01% 2116
2018
Q4
$2.31M Buy
51,800
+200
+0.4% +$10.4K ﹤0.01% 2540
2018
Q3
$2.79M Sell
51,600
-39,200
-43% -$2.01M ﹤0.01% 2422
2018
Q2
$4.43M Buy
90,800
+34,900
+62% +$1.98M ﹤0.01% 1947
2018
Q1
$3.5M Buy
55,900
+20,400
+57% +$1.4M ﹤0.01% 2098
2017
Q4
$2.17M Buy
35,500
+11,800
+50% +$730K ﹤0.01% 2592
2017
Q3
$1.59M Buy
23,700
+6,800
+40% +$481K ﹤0.01% 2907
2017
Q2
$1.32M Buy
16,900
+800
+5% +$60.4K ﹤0.01% 3023
2017
Q1
$1.31M Sell
16,100
-4,600
-22% -$362K ﹤0.01% 2925
2016
Q4
$1.49M Sell
20,700
-7,800
-27% -$564K ﹤0.01% 3274
2016
Q3
$2.21M Buy
28,500
+17,100
+150% +$1.38M ﹤0.01% 2421
2016
Q2
$889K Sell
11,400
-8,500
-43% -$678K ﹤0.01% 3071
2016
Q1
$1.63M Buy
19,900
+500
+3% +$40.7K ﹤0.01% 2750
2015
Q4
$1.73M Sell
19,400
-18,600
-49% -$1.58M ﹤0.01% 2596
2015
Q3
$2.92M Buy
38,000
+11,100
+41% +$928K ﹤0.01% 2132
2015
Q2
$2.25M Buy
26,900
+14,500
+117% +$1.28M ﹤0.01% 2412
2015
Q1
$1.12M Sell
12,400
-89,400
-88% -$7.7M ﹤0.01% 2991
2014
Q4
$8.22M Buy
101,800
+53,400
+110% +$4.22M 0.01% 1422
2014
Q3
$3.63M Sell
48,400
-116,400
-71% -$8.47M ﹤0.01% 2095
2014
Q2
$11.3M Buy
164,800
+129,300
+364% +$8.8M 0.01% 1178
2014
Q1
$2.48M Sell
35,500
-10,500
-23% -$730K ﹤0.01% 2214
2013
Q4
$3.07M Buy
46,000
+6,500
+16% +$397K ﹤0.01% 2210
2013
Q3
$2.06M Buy
39,500
+1,800
+5% +$91.4K ﹤0.01% 2429
2013
Q2
$1.78M Buy
+37,700
New +$1.72M ﹤0.01% 2451

Other funds holding CAH

Citigroup's CAH Position: Q1 2026 in Review

Citigroup reduced its Cardinal Health (CAH) stake by 14% in Q1 2026, selling an estimated $12M and leaving 340,335 shares worth $71.9M. The position accounts for 0.03% of the portfolio, ranked #516.

Citigroup first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.3M in Q4 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Citigroup held 340,335 shares of Cardinal Health worth $71.9M as of Q1 2026.
  • Citigroup sold 55,503 Cardinal Health shares in Q1 2026, an estimated $12M.
  • Cardinal Health made up 0.03% of Citigroup's portfolio in Q1 2026, its #516 holding.
  • Citigroup first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Cardinal Health position peaked at $81.3M in Q4 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.